MedEdTalks Pediatrics is an accredited educational podcast for providers to learn more about treating patients with Pediatrics diseases/disorders. Discover all content and topics by visiting mededtalks.com.
Overcoming HPV Vaccine Hesitancy With Drs. Charles P. Vega and Anne Teitelman
In this podcast, expert clinicians discuss strategies for overcoming HPV vaccine hesitancy.
24 Jun 2022
HPV Vaccination Schedules in Pediatric Patients With Drs. Charles P. Vega and Stan L. Block
In this podcast, expert clinicians discuss HPV vaccination schedules for pediatric patients.
24 Jun 2022
Understanding the Risk of HPV Infection With Drs. Charles P. Vega and Rachel N. Caskey
In this podcast, expert clinicians will discuss the risk of HPV infection.
24 Jun 2022
Understanding the Burden of Pediatric HPV With Drs. Charles P. Vega and Stan L. Block
In this podcast, expert clinicians will discuss the burden of pediatric HPV infection.
31 Aug 2020
Dr. Charles Vega and Dr. Michael Simon Discuss a Case Involving a High-Risk Patient With Influenza
While the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention (CDC) estimates that influenza has resulted in between 9.2 million and 35.6 million illnesses, between 140,000 and 710,000 hospitalizations, and between 12,000 and 56,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. Antivirals with different targets and different mechanisms of action provide multiple therapeutic options and hold promise in improving treatment effectiveness, especially in pediatric and adolescent patients. In this podcast series, expert clinicians will discuss the latest evidence regarding the use of antiviral agents for the treatment of patients with influenza who are at normal or high risk for complications and the use of antiviral agents for influenza treatment based on their efficacy and ability to reduce the transmission of the disease.
For CME Credit, click here: https://tinyurl.com/pediatricss1e3
31 Aug 2020
Dr. Paul Auwaerter and Dr. Charles Vega Review the Therapies Used to Treat Influenza
While the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention (CDC) estimates that influenza has resulted in between 9.2 million and 35.6 million illnesses, between 140,000 and 710,000 hospitalizations, and between 12,000 and 56,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. Antivirals with different targets and different mechanisms of action provide multiple therapeutic options and hold promise in improving treatment effectiveness, especially in pediatric and adolescent patients. In this podcast series, expert clinicians will discuss the latest evidence regarding the use of antiviral agents for the treatment of patients with influenza who are at normal or high risk for complications and the use of antiviral agents for influenza treatment based on their efficacy and ability to reduce the transmission of the disease.
For CME Credit, click here: https://tinyurl.com/pediatricss1e2
31 Aug 2020
Dr. Paul Auwaerter and Dr. Charles Vega Discuss the Latest in Diagnosing and Managing Patients With Influenza
While the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention (CDC) estimates that influenza has resulted in between 9.2 million and 35.6 million illnesses, between 140,000 and 710,000 hospitalizations, and between 12,000 and 56,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. Antivirals with different targets and different mechanisms of action provide multiple therapeutic options and hold promise in improving treatment effectiveness, especially in pediatric and adolescent patients. In this podcast series, expert clinicians will discuss the latest evidence regarding the use of antiviral agents for the treatment of patients with influenza who are at normal or high risk for complications and the use of antiviral agents for influenza treatment based on their efficacy and ability to reduce the transmission of the disease.
For CME Credit, complete activity here: https://tinyurl.com/pediatricss1e1
4 Aug 2020
Influenza Update! Advanced Practice Pearls on Treatment
This CME/CNE series is targeted to pediatric nurse practitioners and other health care professionals involved in the management of patients with influenza.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
4.0 / 5
1 ratings
Contact MedEdTalks - Pediatrics
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of MedEdTalks - Pediatrics?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
